Chronic Gingivostomatitis Treatment Market
- 2026 年市場規模
- USD 20,100 Mn
- 2033 年預估規模
- USD 31,200 Mn
- 年複合成長率 CAGR
- 6.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Chronic Gingivostomatitis Treatment Market, By Diagnosis (Physical Examination, Microbial Culture, Biopsy, Others), By Treatment (Non-steroidal Anti-inflammatory Drugs, Antiviral, Antibacterial, Others), By End User (Hospitals & Clinics, Academic & Research, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Gingivostomatitis is a contagious mouth infection, which causes painful sores, blisters, and swelling in the tongue and uvula. It usually spreads through the saliva of an infected individual or by direct contact with a lesion or sore. Gingivostomatitis is also called as herpetic, which is caused by herpes simplex virus and is the most common cause of gingivostomatitis. Gingivostomatitis is the most common among young children, usually under 6 years old, but it may also occur in adults. Geriatric people may experience severe symptoms than adults and children.
Market Dynamics
Rising incidence of gingivostomatitis caused by herpes simplex virus (HSV) is expected to drive the chronic gingivostomatitis treatment market growth. For instance, according to the International Journal of Dentistry, an article published in October 2016, reports that over 90% of gingivostomatitis cases are caused by herpes simplex virus (HSV) type 1 and the remainder are caused by herpes simplex virus (HSV) type 2.
However, lack of identification or diagnosis of chronic gingivostomatitis are expected to hinder the market growth. For instance, according to the Journal of Dental Health Oral Disorders & Therapy, an article published in 2017, states that chronic gingivostomatitis may be asymptomatic in some instances, may be unnoticed in some instances, and sometimes get misdiagnosed with other chronic mouth ulcers.
Key features of the study
• This report provides in-depth analysis of the global chronic gingivostomatitis treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global chronic gingivostomatitis treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study are Pfizer Inc., Taj Pharmaceutical limited, Ciron pharma, Johnson & Johnson, GlaxoSmithKline PLC, Merck & CO., Inc., Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, and AstraZeneca Plc. among others
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
• The global chronic gingivostomatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic gingivostomatitis treatment market
Market Segmentation
• By Diagnosis (Revenue, USD Mn, 2021-2033)
o Physical Examination
o Microbial Culture
o Biopsy
o Others
• By Treatment (Revenue, USD Mn, 2021-2033)
o Non-steroidal Anti-inflammatory Drugs
o Antiviral
o Antibacterial
o Others
• By End User (Revenue, USD Mn, 2021-2033)
o Hospitals & Clinics
o Academic & Research
o Others
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Pfizer Inc.
o Taj Pharmaceutical Limited
o Ciron Pharma
o Johnson & Johnson
o GlaxoSmithKline PLC
o Merck & Co., Inc.
o Novartis AG
o Hoffmann-La Roche AG
o Eli Lilly and Company
o AstraZeneca Plc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Diagnosis
Market Snippet, By Treatment
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Pipeline Analysis
o Reimbursement Scenario
o Epidemiology
o Pest Analysis
o Regulatory Scenario
o New Product Launches
o Collaborations and Agreements
o Market Trends
4. Global Chronic Gingivostomatitis Treatment Market, By Diagnosis, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Physical Examination
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Microbial Culture
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Biopsy
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Chronic Gingivostomatitis Treatment Market, By Treatment, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Non-steroidal Anti-inflammatory Drugs
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Antiviral
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Antibacterial
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Chronic Gingivostomatitis Treatment Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026, and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals & Clinics
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Academic & Research
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Chronic Gingivostomatitis Treatment Market, By Region, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2022 - 2033
o North America
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o U.S.
o Canada
o Latin America
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Diagnosis, 2021-2033, (USD Mn)
Market Size and Forecast, By Treatment, 2021-2033, (USD Mn)
Market Size and Forecast, By End User, 2021-2033, (USD Mn)
Market Size and Forecast, By Country, 2021-2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Taj Pharmaceutical limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Ciron pharma
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson & Johnson
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline PLC
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Merck & CO., Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hoffman La Roche AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Eli Lily and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
AstraZeneca Plc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們